Digital marketing service provider Cansince (KASH.US) plans to price its IPO at $5 per share, aiming to raise $15 million.
Cansince Innovations plans to issue 3 million shares of stock at a price of $5 per share, raising $15 million.
Hong Kong digital marketing service provider Cansince Innovations raised its upcoming initial public offering (IPO) issuance size on Tuesday. The company, based in Hong Kong, plans to issue 3 million shares at a price of $5 per share, raising $15 million. Previously, the company had applied to issue 1.5 million shares at $4 per share. Based on the revised terms, Cansince Innovations' fundraising size will increase by 150% from the previous expectations. The company plans to list on Nasdaq with the stock code "KASH".
According to information, Cansince Innovations provides marketing services through its operating subsidiary Vnique, covering three core areas: strategic planning, content creation, and influencer collaboration solutions. Its services include brand positioning, market research, website and social media management, graphic and video production, as well as coordinating collaborations with influencers in industries such as food and beverage, technology, healthcare, and work and lifestyle. Data shows that the company achieved sales of $5 million in the 12 months ending July 31, 2025.
Related Articles

New Stock News | MeiG Smart Technology (002881.SZ) holds a 6.4% share of the global wireless communication module market through a hearing at the Hong Kong Stock Exchange.

New stock news | Bonasia submits listing application to the Hong Kong Stock Exchange Main Board

New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) submits listing application to Hong Kong Stock Exchange.
New Stock News | MeiG Smart Technology (002881.SZ) holds a 6.4% share of the global wireless communication module market through a hearing at the Hong Kong Stock Exchange.

New stock news | Bonasia submits listing application to the Hong Kong Stock Exchange Main Board

New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) submits listing application to Hong Kong Stock Exchange.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


